13.47 USD
▼-0.41-2.95%
盘后 13.44 0.00%
2026-09-15
市值
$170.67M
市盈率
—
EPS
-2.25
股息率
—
52 周区间
12.52 – 20.03
成交量
80.53K
Beta
0.14
目标价
29.83
52W 低 12.5252W 高 20.03
价格走势
公司简介
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other ...